Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07412665 | A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors. | not yet recruiting | Early Phase 1 | 10 | Beijing Geekgene Technology Co., LTDINDUSTRY | 1 | Jun 25, 2026 | clinicaltrials |
| NCT07657611 | Inhaled mRNA Immunotherapy for Patients With Advanced Lung Cancer or Pulmonary Metastatic Solid Tumors(BMD-PLAT) | not yet recruiting | Early Phase 1 | 60 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER |
| 0 |
| Jun 18, 2026 |
| clinicaltrials |
| NCT07504445 | Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 10 | Peking University Shenzhen HospitalOTHER | 1 | Jun 3, 2026 | clinicaltrials |
| NCT07621471 | IL-15 Enhanced NK Cell Therapy for Solid Tumors | not yet recruiting | Early Phase 1 | 12 | Genovn Therapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Jun 2, 2026 | clinicaltrials |
| NCT07583953 | An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors | not yet recruiting | Early Phase 1 | 50 | Suzhou Abogen Biosciences Co., Ltd.INDUSTRY | 0 | May 13, 2026 | clinicaltrials |
| NCT07342738 | TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 25 | Sun Yat-sen UniversityOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT06976931 | Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer | not yet recruiting | Early Phase 1 | 42 | Jiangsu YaYao Biotechnology Co., Ltd.INDUSTRY | 0 | May 16, 2025 | clinicaltrials |
| NCT06951425 | An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors | not yet recruiting | Early Phase 1 | 24 | Shanghai Tongji Hospital, Tongji University School of MedicineOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06825455 | Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 18 | Peking UniversityOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT06713148 | Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 42 | Fudan UniversityOTHER | 0 | Feb 6, 2025 | clinicaltrials |
| NCT06619886 | TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor | not yet recruiting | Early Phase 1 | 9 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 1, 2024 | clinicaltrials |
| NCT06613152 | HS-IT201 Injection in the Treatment of Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 9 | Qingdao Sino-Cell Biomedicine Co., Ltd.INDUSTRY | 0 | Sep 25, 2024 | clinicaltrials |
| NCT05539768 | Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor | not yet recruiting | Early Phase 1 | 8 | The Affiliated Hospital of Qingdao UniversityOTHER | 0 | Sep 14, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Jun 25, 2026source: clinicaltrials